- Users can learn about the indications for anticoagulation bridge therapy in patients with pulmonary embolism, including the presence of risk factors for thrombosis and the need for temporary interruption of anticoagulation therapy.
- The simulation provides insights into the selection of appropriate anticoagulants for bridge therapy, considering factors such as the patients renal function, risk of bleeding, and the need for rapid onset of action.
- Users can practice monitoring patients undergoing bridge therapy for signs of bleeding or thrombosis, as well as managing any complications that may arise.
- The simulation aims to improve users ability to educate patients about anticoagulation bridge therapy, including the reasons for its use, potential side effects, and the importance of adherence to therapy.